Mandate

Vinge advises Active Biotech on directed new share issue

April 06, 2010

The biotechnology company, Active Biotech (NASDAQ OMX Stockholm) is carrying out a directed new issue of shares for approximately SEK 149 million to funds managed by Sectoral Asset Management Inc. Vinge is acting for Active Biotech.

Vinge’s team consists of Erik Sjöman and Christian Lindhé.

Related

Vinge has assisted KMC Properties in its merger with Logistea

On June 14, 2024, KMC Properties ASA, listed on Oslo Børs, announced that the company is merging with Logistea AB (publ), listed on Nasdaq Stockholm.
June 24, 2024

Vinge advises Cinclus Pharma in connection with listing on Nasdaq Stockholm

Vinge advises Cinclus Pharma Holding AB (publ) (“Cinclus Pharma”) in connection with an offering of new ordinary shares and listing on Nasdaq Stockholm. The first day of trading is 20 June 2024.
June 20, 2024

Vinge advises Axcel VI and the Currentum in connection with the acquisition of Elektro-Emanuel

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elektro-Emanuel AB. The company carries out electrical installations for both companies and private individuals and has offices in four cities in western Sweden.
June 19, 2024